AtheroGenics, Inc.{AGIX}-nasdaq Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AtheroGenics, Inc.{AGIX}-nasdaq

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sim1 who wrote (42)	5/22/2001 4:52:53 PM
From: sim1	of 332

AtheroGenics Inc Raised to 'Strong Buy' at Adams, Harkness 5/22/01 5:45 AM Source:Bloomberg News Princeton, New Jersey, May 22 (Bloomberg Data) -- AtheroGenics Inc. (AGIX US) was raised to ''strong buy'' from ''buy'' by analyst Carol A Werther at Adams, Harkness & Hill. The 2001 year-end price target is $15 per share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next